Erdal et al. (2021) verified a significant correlation between endocan and high-sensitivity C-reactive protein levels in patients diagnosed with silent brain infarction (r = 0.196, P = 0.16), which may illustrate the pro-inflammatory roles of endocan in ischemic stroke to some extent. The gene discussed is ESM1; the disease is ischemic stroke.